Watch CBS News

Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials

Johnson & Johnson announced that their new single-dose vaccine showed 85% protection against severe cases of COVID-19. Some advantages of the new vaccine: it's a single dose and can be stored in a regular refrigerator. Dr.Tara Narula details how this new vaccine works.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.